Sato F - Search Results

1

Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

Aoki T, Nishimura H, Nakagawa S, Kojima J, Suzuki H, Tamaki T, Wada Y, Yokoo N, Sato F, Kimata H, Kitahara M, Toyoda K, Sakashita M, Saito Y. Aoki T, et al. Among authors: sato f. Arzneimittelforschung. 1997 Aug;47(8):904-9. Arzneimittelforschung. 1997. PMID: 9296275

2

Triglyceride-lowering effect of pitavastatin in a guinea pig model of postprandial lipemia.

Aoki T, Yamazaki H, Tamaki T, Sato F, Kitahara M, Saito Y. Aoki T, et al. Among authors: sato f. Arzneimittelforschung. 2003;53(3):154-8. doi: 10.1055/s-0031-1297088. Arzneimittelforschung. 2003. PMID: 12705169

3

Effect of pitavastatin on sterol and bile acid excretion in guinea pigs.

Aoki T, Yamazaki H, Maejima T, Sato F, Kitahara M, Saito Y. Aoki T, et al. Among authors: sato f. Arzneimittelforschung. 2003;53(5):351-6. Arzneimittelforschung. 2003. PMID: 12854362

4

Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ubiquinone levels in rat skeletal muscle and heart: relationship to cytotoxicity and inhibitory activity for cholesterol synthesis in human skeletal muscle cells.

Yamazaki H, Suzuki M, Aoki T, Morikawa S, Maejima T, Sato F, Sawanobori K, Kitahara M, Kodama T, Saito Y. Yamazaki H, et al. Among authors: sato f. J Atheroscler Thromb. 2006 Dec;13(6):295-307. doi: 10.5551/jat.13.295. J Atheroscler Thromb. 2006. PMID: 17192694 Free article.

5

Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs.

Suzuki H, Aoki T, Tamaki T, Sato F, Kitahara M, Saito Y. Suzuki H, et al. Among authors: sato f. Atherosclerosis. 1999 Oct;146(2):259-70. doi: 10.1016/s0021-9150(99)00146-x. Atherosclerosis. 1999. PMID: 10532682

6

Lipid-lowering and antiatherosclerotic effect of NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits.

Suzuki H, Yamazaki H, Aoki T, Kojima J, Tamaki T, Sato F, Kitahara M, Saito Y. Suzuki H, et al. Among authors: sato f. Arzneimittelforschung. 2000 Nov;50(11):995-1003. doi: 10.1055/s-0031-1300323. Arzneimittelforschung. 2000. PMID: 11187394

7

Hypolipidemic effect of NK-104 and other 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in guinea pigs.

Suzuki H, Yamazaki H, Aoki T, Tamaki T, Sato F, Kitahara M, Saito Y. Suzuki H, et al. Among authors: sato f. Arzneimittelforschung. 2001 Jan;51(1):38-45. doi: 10.1055/s-0031-1300000. Arzneimittelforschung. 2001. PMID: 11215324

8

Cholesterol-lowering effect of NK-104, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, in guinea pig model of hyperlipidemia.

Aoki T, Yamazaki H, Suzuki H, Tamaki T, Sato F, Kitahara M, Saito Y. Aoki T, et al. Among authors: sato f. Arzneimittelforschung. 2001;51(3):197-203. doi: 10.1055/s-0031-1300025. Arzneimittelforschung. 2001. PMID: 11304935

9

Triglyceride-lowering effect of pitavastatin [corrected] in a rat model of postprandial lipemia.

Aoki T, Yoshinaka Y, Yamazaki H, Suzuki H, Tamaki T, Sato F, Kitahara M, Saito Y. Aoki T, et al. Among authors: sato f. Eur J Pharmacol. 2002 May 24;444(1-2):107-13. doi: 10.1016/s0014-2999(02)01547-9. Eur J Pharmacol. 2002. PMID: 12191589

10

[Pharmacological and pharmacokinetic features and clinical effects of pitavastatin (Livalo Tablet)].

Yamazaki H, Fujino H, Kanazawa M, Tamaki T, Sato F, Suzuki M, Kitahara M. Yamazaki H, et al. Among authors: sato f. Nihon Yakurigaku Zasshi. 2004 May;123(5):349-62. doi: 10.1254/fpj.123.349. Nihon Yakurigaku Zasshi. 2004. PMID: 15118259 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,795 results

Search Page